INTRODUCTION
The stroke-prone spontaneously hypertensive strain of rats is a substrain of spontaneously hypertensive rats SHR , which were spontaneously developed as a colony from normotensive Wistar Kyoto rats WKY 1 3 . The cerebral blood flow has been confirmed during the development of hypertension in SHRSP. Thus, the etiology of stroke in these rats is essentially similar to that in humans 2 4 .
In addition to severe hypertension, SHRSP exhibit a series of cardiovascular disorders such as salt sensitivity, stress sensitivity and the propensity for end-organ damage 5, 6 .
SHRSP develop severe nephrosclerosis and hypertensioninduced renal injury as well 2, 7 . SHRSP also exhibit behavioral abnormalities including increased ambulatory activity and disrupted circadian rhythms; these behavioral abnormalities are considered to correspond to the delirium state observed in patients with dementia after cerebrovascular accidents 8 . On the one hand, SHRSP are hyper-responders to cholesterol feeding and easily develop hyperlipidemia and arterial fat deposition 9 . SHR, which present with a predisposition to insulin resistance, have been used to identify genes contributing to metabolic syndrome 10 . In this context, not a small number of studies have utilized SHRSP as a model of not only stroke but also disorders of lipid metabolism, in particular the early changes underlying the development of metabolic syndrome 11 . Thus, SHRSP are considered to be useful for study of the pathogenesis of the above-mentioned disorders and for testing of likely prophylactic compounds against them. Many types of compound, including drugs, dietary oils, fatty acids and other nutrients, have been tested so far. From these studies, several types of fatty acid and dietary oil have been demonstrated to affect prevent, ameliorate or exacerbate the above-mentioned disorders 12 18 .
Attention has been increasingly focused on the quality rather than the quantity of fatty acids since fatty acid species are of crucial importance for many physiological processes, such as de novo lipogenesis 19 , gluconeogenesis 20 , triacylglycerol TAG synthesis 21 , secretion of verylow density lipoprotein 22 , endoplasmic reticulum stress 23 , insulin sensitivity 24 and obesity 25 . These findings emphasize the importance of understanding the mechanism regulating the production of fatty acid species. Moreover, the liver plays a key role in whole-body fatty acid metabolism, and fatty acid species that exist in the liver are considered to be pathophysiologically critical 23, 26, 27 . With regard to SHRSP, the lipid profile and fatty acid profile in renal membrane have been studied in relation to hypertension 28 . To the best of our knowledge, however, information on the profile of fatty acids and lipids in the liver and serum of SHRSP is lacking; moreover, the mechanism underlying the changes in fatty acid metabolism in the liver of SHRSP is unclear. This information is indispensable to establish SHRSP as a useful model for pathophysiological study of lipid metabolism. In this context, the aims of this study are 1 to explore profiles of fatty acids and lipids in the liver and serum of SHRSP and 2 to investigate the mechanism underlying characteristic alterations in the metabolism of TAGs and fatty acids in the liver of SHRSP in comparison with SHR.
EXPERIMENTAL PROCEDURES

Materials
The following materials were obtained from the indicated commercial sources: l-U- 14 
Animals
All animal procedures were approved by Josai University s Institutional Animal Care Committee in accordance with the Guidelines for Proper Conduct of Animal Experiments Science Council of Japan . Fifteen-week-old male WKY, SHR and SHRSP were obtained from SLC Hamamatsu, Japan . The animals were fed on a standard diet CE-2; Clea Japan, Tokyo, Japan ad libitum and allowed free access to water. After acclimatization, at the age of 22 weeks, the rats were anesthetized with diethyl ether. Blood was collected from the inferior vena cava and the liver was rapidly removed. Serum was obtained from the blood by centrifugation. The livers were washed with saline and weighed. For analyses of lipids and determination of mRNA, small portions of the liver were frozen in liquid nitrogen and stored at 80 . The residual portion of the liver was perfused with ice-cold saline and used for the preparation of cytosol and microsomes.
Preparation of cytosol and microsomes
One portion of the liver was homogenized with 1.5 volumes of a phosphate-bicarbonate buffer 70 mM KHCO 3 /85 mM K 2 HPO 4 /9 mM KH 2 PO 4 /1 mM dithiothreitol pH 8.0 in a Potter glass-Teflon homogenizer. The homogenates were centrifuged at 20,000 g for 10 min, and the supernatant was centrifuged at 105,000 g for 60 min. The resulting supernatant was used as cytosol. The other portion of the perfused livers was used for the preparation of microsomes as described previously 29 . All operations were carried out at 0 4 . Protein concentrations in the preparations were determined by the method of Lowry et al. 30 using bovine serum albumin as a standard.
Analytical procedures
Total lipid was extracted from portions of livers and serum by the method of Bligh and Dyer 31 . Cholesterol in the liver and serum was measured by the method of Zurkowski 32 ; lipid phosphorus was measured according to
Rouser et al. 33 . TAG was separated by thin-layer chromatography on silica gel G plates, which were developed with n-hexane/diethyl ether/acetic acid 80:30:1, by vol. . After visualization by spraying 0.001 w/v primuline in 80 acetone, the regions that corresponded to TAG were scraped off and transferred to tubes. TAG was extracted from silica gel as described previously 29 , and determined by an enzymatic method using a commercially available kit Triglyceride E-Test Wako; Wako Pure Chemical Industries, Ltd., Osaka, Japan essentially according to Flowers et al. 34 . TAG in serum was directly determined by the enzymatic method mentioned above. Glycogen contents in the livers were measured by the enzymatic method as described previously 35 .
To determine the acyl composition of lipid classes, total lipids were extracted from portions of livers by the method of Bligh and Dyer 31 , after the additions of known amounts of nonadecanoic acid, cholesteryl heptadecanoate and triheptadecanoin as internal standards. The acyl composition of hepatic total lipids was determined as methyl esters of fatty acids by gas chromatography Shimadzu GC-2014; Shimadzu, Kyoto, Japan as described previously 36 . For cholesteryl ester CE , TAG, unesterified fatty acid FFA , diacylglycerol DAG and phospholipid PL , these lipids were separated by thin-layer chromatography on silica gel G plates, which were developed with n-hexane/diethyl ether/acetic acid 80:30:1, by vol. . After visualization by spraying 0.001 w/v primuline in 80 acetone, the regions on each plate that corresponded to specific lipids were scraped off and transferred to tubes. To the assay tubes containing PL or DAG, were added known amounts of methyl heptadecanoate as internal standards. The lipids were extracted from silica gel as described previously 29 .
Methyl esters of fatty acids were prepared from each extract using sodium methoxide/methanol for DAG, TAG and PL and using HCl/methanol for FFA. CE, which was extracted from silica gel, was saponified; then, the fatty acids released were extracted separately from cholesterol and converted to methyl esters using boron trifluoride/ methanol. The acyl composition of these lipids was determined as methyl esters of fatty acids by gas chromatography.
2.5 RNA extraction and quanti cation of gene expression Total RNA was isolated from the liver tissues using QIAzol reagent and RNeasy kit QIAGEN, Hilden, Germany . cDNA was synthesized from 500 ng of total RNA with avian myeloblastosis virus reverse transcriptase Takara, Shiga, Japan . Polymerase chain reaction PCR amplification was carried out using SYBR Premix EX Taq 2x Perfect Real Time; Takara . The amplification and detection were performed with Applied Biosystems 7500 real time PCR system Life Technologies Corp., Carlsbad, CA, U.S.A. . The thermal cycling program was as follows: 10 s denaturation step at 95 , followed by 50 cycles of 5 s denaturation at 95 and 34 s annealing at 60 . Melting curve analysis was performed to confirm the real-time PCR products. Changes in gene expression were calculated by using the comparative threshold cycle Ct method. Ct values were first normalized by subtracting the Ct value obtained from β-actin control . The sequences of primers used in this study are listed in Table 1 .
Enzyme assays
The activity of fatty acid synthase FAS in cytosol was determined by the method of Nepokroeff et al. 37 . In brief, the assay mixture contained 33 nmol acetyl-CoA, 100 nmol NADPH, 1 μmol ethylenediaminetetraacetic acid, 1μmol 2-mercaptoethanol, 100 μg of cytosolic protein and 0.1 M potassium phosphate buffer pH 7.0 in a final volume of 1 mL. Incubation was performed at 30 , and the rate of NADPH-oxidation was monitored at 340 nm. The substrate-dependent rate was determined by subtracting the NADPH oxidation rate from the rate after adding malonylCoA. Glycerol-3-phosphate acyltransferase GPAT activity in microsomes was determined according to Yamada 40 . In brief, the assay mixture contained 15 nmol palmitoyl-CoA or palmitoleoyl-CoA, 100 nmol 2-14 C malonyl-CoA 20 nCi , 12 nmol bovine serum albumin, 0.5 μmol KCN, 250 μg of microsomal protein and 100 mM Tris-HCl pH 7.4 in a total volume of 0.5 mL. The control value, which was obtained from incubation without acyl-CoA, was subtracted to give the net condensation rate for palmitoylCoA or palmitoleoyl-CoA. 
Statistical analyses
Homogeneity of variance was established using one-way analysis of variance. When a difference was significant p 0.05 , Scheffé s multiple range test was used as a post-hoc test. The results were considered to be significant if the value of p was 0.05.
RESULTS
Physiological parameters
Selected parameters of SHRSP were compared with those of SHR and WKY Table 1 Continued.
ferences were observed in hepatic content of lipid phosphorus among the three groups of rats. However, the hepatic content of glycogen in SHRSP was 49 of that in SHR, but no significant difference was found in this regard between WKY and SHR. As for TAGs, cholesterol and lipid phosphorus in serum, there were no significant differences in the concentrations between SHRSP and SHR. However, the serum concentration of TAGs in SHRSP was 180 of that in WKY. In contrast, the serum level of cholesterol in SHRSP was 76 of that in WKY, but there were no differences in serum cholesterol level between SHRSP and SHR. No substantial differences were found in the serum concentration of lipid phosphorus among WKY and SHR or SHRSP. There were also no significant differences in serum glucose levels among the three groups of rats. Figure 1 shows the differences in content μmol/g liver of particular fatty acids between two groups of rats. The results indicate that the dissimilarity of fatty acid profile between SHRSP and SHR was attributable to the altered contents of 16:1n-7, 18:1n-7, 18:1n-9, 18:0 and 18:2n-6.
Gene expression in the liver
The mRNA abundance of key enzymes and proteins that are involved in lipogenesis, fatty acid modification, fatty acid trafficking and lipid degradation in the liver was measured Table 4 . There were no notable differences in hepatic levels of mRNAs encoding the enzymes that are involved in de novo fatty acid synthesis FAS, acetyl-CoA carboxylase 1 ACC1 , ATP-citrate lyase ACLY and malic enzyme 1 ME1 and glycerolipid synthesis GPAT1, GPAT4, DGAT1 and DGAT2 . With regard to the enzymes linked to fatty acid modification, levels of mRNAs encoding fatty acid desaturase Fads 2 and fatty acid elongase Elovl 5 in the liver of SHRSP were 342 and 67 , respectively, of those of SHR; they were also130 and 45 , respectively, of those of WKY. The level of Elovl5 mRNA in SHR was 67 and 149 , respectively, of those of WKY and SHRSP. Differently from SHRSP, the expression of mRNAs for Fads2, Elovl1, Elovl2 and Elovl6 in the liver of SHR was considerably lower than that of WKY. However, there were no significant differences in the expression of genes for SCD1, SCD2 and Fads1 among the three groups of rats. As for proteins and enzymes that are involved in fatty acid trafficking, a characteristic difference was observed in the expression of mRNA encoding long-chain acyl-CoA synthetase ACSL 3 between SHRSP and SHR: the level of mRNA for ACSL3 in the liver of SHRSP was 66 and 69, of those of SHR and WKY, respectively. There were no significant differences in the levels of mRNAs for fatty acid translocase FAT/CD36 , fatty acid transport proteins FATP2, FATP4 and FATP5 , fatty acid binding proteins FABP1 and FABP5 , plasma membrane-associated fatty acid binding protein FABPpm and ACSLs ACSL1, ACSL4 and ACSL5 between SHRSP and SHR. It is noteworthy that the levels of mRNA encoding FAT/CD36 in the liver of SHR and SHRSP were 11 and 31 , respectively, of that of WKY and that the levels of mRNA encoding FABPpm in the liver of SHR and SHRSP were 55 and 65 , respectively, of that of WKY. In terms of enzymes and proteins related to lipid degradation, the levels of mRNAs encoding adipose triglyceride lipase ATGL and carnitine palmitoyltransferase 1a CPT1a in the liver of SHRSP were 156 and 446 , respectively, of those of SHR. There was no difference in the expression of the gene for medium-chain acyl-CoA dehydrogenase MCAD between SHRSP and SHR; their levels were approximately 60 of that of WKY. The level of mRNA for long-chain acyl-CoA dehydrogenase LCAD in the liver of SHRSP was significantly higher than that of SHR, but no significant difference was found in this regard between SHRSP and WKY. There were also no significant differences in the mRNA level of comparative gene identification-58 CGI-58 among SHRSP, SHR and WKY. Concerning nuclear transcription factors, there were no differences in the levels of mRNAs for sterol regulatory element binding protein-1c SREBP-1c , carbohydrate responsive elementbinding protein ChREBP , peroxisome proliferator-activated receptor α PPARα and liver X receptor α LXRα between SHRSP and SHR. The levels of expression of the gene for LXRα in the liver of SHR and SHRSP were 57 and 55 , respectively, of that of WKY. However, there were no significant differences in the expression of the genes for L-type pyruvate kinase LPK , phosphoenolpyruvate car- Table 3 . boxykinase PEPCK , glucokinase GK , glucose-6-phosphatase G6Pc and glucose transporter 2 GLUT2 among the three groups of rats.
Enzyme activities in the liver
There were no significant differences in the activities of cytosolic FAS, microsomal GPAT, microsomal DGAT, microsomal SCD and microsomal PCE in the liver between SHRSP and SHR Fig. 2A-E . The activity of DGAT in SHRSP was slightly lower 77 than that of WKY Fig.  2C . The activity of POCE in hepatic microsomes of SHRSP was 60 and 38, of those of SHR and WKY, respectively Fig. 2F .
Fatty acid pro ling of the liver and serum
The fatty acid profiles of lipid classes, TAG, DAG, CE, FFA and PL, in the liver of SHRSP were compared with those of SHR and WKY Table 5 . Total contents of fatty acids of TAG and CE in the liver of SHRSP were 49 and 68 , respectively, of those of SHR; however, no significant differences in the contents of fatty acids of DAG, FFA and PL were found between SHRSP and SHR. There were also no considerable differences in total fatty acid contents in all lipid classes between SHR and WKY. As for the fatty acid profiles of lipid classes, evident differences were observed in TAG, DAG, CE and PL between SHRSP and SHR. Namely, the proportions of 16:1n-7, 18:1n-7 and 18:2n-6 in TAG in the liver of SHRSP were 61, 65 and 82 , respectively, of those of SHR; those of 16:0 and 18:0 were 123 and 209 , respectively, of those of SHR. The differences in the proportions of fatty acids in DAG between SHRSP and SHR tended to be similar to those in TAG, but they were not as pronounced. The proportions of 18:1n-9, 18:1n-7, 18:2n-6 and 20:4n-6 in CE of SHRSP were 69, 50, 40 and 29 , respectively, of those of SHR; those of 16:0 and 18:0 were 141 and 138 , respectively, of those of SHR. With regard to Table 5 Fatty acid profile of TAG, DAG, CE, FFA and PL in the liver.
Hepatic fatty acid profile of stroke-prone spontaneously hypertensive rat PL, the proportions of 18:1n-7 and 18:0 were 57 and 116 , respectively, those of SHR. No substantial change was observed in the fatty acid profile of FFA in SHRSP. The alterations that were brought about in the proportions of fatty acids of these lipid classes in the liver of SHR were not as evident as those of SHRSP. Table 6 shows the fatty acid profiles of TAG and PL in serum. The proportions of 16:0, 16:1n-7, 18:1n-7 and 18:2n-6 in serum TAG of SHRSP were 115, 65, 74 and 86 , respectively, of those of SHR. As for serum PL, the proportions of 18:0 and 18:1n-7 in SHRSP were 113 and 59 , respectively, of those in SHR. The proportions of 18:1n-9 in serum PL of SHR and SHRSP were slightly but significantly higher than that of WKY.
DISCUSSION
The present study clearly showed that the profile of lipid classes in the liver and serum of SHRSP was quite similar to that of SHR, except for one large difference in the hepatic content of TAGs. The content of TAGs in the liver of SHRSP was approximately half of that of SHR, suggesting that TAG metabolism is altered in the liver of SHRSP. To gain insight into the molecular basis of the alterations in TAG metabolism in the liver of SHRSP, we compared the expression of the genes encoding enzymes and proteins that are involved in lipogenesis, fatty acid trafficking and lipid degradation in the liver of SHRSP with those of SHR. Among the genes examined, the expression of the genes for ATGL and CPT1a was significantly up-regulated and that of the ACSL3 gene was down-regulated in SHRSP. On the other hand, there were no differences in the expression of genes other than the three mentioned above in the liver between SHRSP and SHR, namely the genes that encode enzymes and proteins that participate in de novo fatty acid synthesis FAS, ACC1, ACLY and ME1 and TAG synthesis GPAT1, GPAT4, DGAT1 and DGAT2 . These results were consistent with the current data showing that no differences were found in the activities of FAS, GPAT and DGAT between SHRSP and SHR. ATGL is a key enzyme that is responsible for hydrolyzing the first fatty acid from TAGs and is considered to be a major hepatic lipase that regulates TAG turnover and fatty acid partitioning 41 . CPT1a is responsible for transporting long-chain fatty acids through the outer mitochondrial membrane for the purpose of β-oxidation in the mitochondrial matrix. This enzyme is considered to catalyze the rate-limiting step in β-oxidation and to play a pivotal role in controlling TAG content in the liver 42 . ACSL3 has been shown to be involved in the formation of lipid droplets in conjunction with the increased production of acyl-CoAs 43 ; moreover, ACSL3 regulates lipogenic transcription factors to control glycerolipid synthesis 44 . Taking these findings together, it is logical to suggest that increases in the hydrolysis of TAG and subsequent β-oxidation of fatty acids, and a decrease in the synthesis of acyl-CoA supplied to TAG synthesis cause the reduced hepatic content of TAGs in SHRSP. In contrast to hepatic TAG, the level of TAGs in the serum of SHRSP was similar to that of SHR and was considerably higher than that of WKY. However, the detailed mechanisms by which hypertriglyceridemia is produced in SHRSP and SHR are not known. The present study also showed that cholesterol levels in the liver and serum in SHRSP as well as SHR were lower than those in WKY. These results are virtually consistent with the conclusion derived from previous studies, which demonstrated the delayed decay of cholesterol in the serum of SHRSP 45 and the reduced activity of cholesterol synthesis in the liver of SHRSP 46 . As a result, serum Differences in means in the same row without a common superscript (a, b, c) are statistically significant (p < 0.05). If no superscript appears, the differences in means are not significant (p > 0.05 ). Table 5 Continued. levels of cholesterol of SHRSP and SHR were significantly lower than those of WKY. Although hepatic content of glycogen in SHRSP was considerably lower than that of SHR, there was no significant difference in the expression of genes for LPK, PEPCK, GK, G6Pc and GLUT2. Moreover, no difference was found in the serum level of glucose between SHRSP and SHR. Therefore, it is most likely that the supply of substrates for synthesis of de novo fatty acids and TAGs, acetyl-CoA and glycerol-3-phosphate, is not affected.
Another major finding of the present study is that the fatty acid profile in total hepatic lipids of SHRSP was dissimilar to that of SHR, despite the fact that there were no large differences in fatty acid profile in hepatic total lipids between SHR and WKY, except for a higher proportion of 22:6n-3 in SHR. The characteristic changes brought about in the fatty acid profile in hepatic total lipids of SHRSP were decreases in the proportions of monounsaturated fatty acids, in particular 18:1n-7, and an increase in that of 18:0. The reduced proportion of 18:1n-7 and the elevated proportion of 18:0 were common among TAG, DAG, CE and PL in the liver of SHRSP. In general, the changes in fatty acid profile in the liver are sequentially relayed to the fatty acid composition of serum lipids 47 . In accordance with the obtained findings, the changes that were brought about in the fatty acid composition of TAG and PL in the liver of SHRSP were relayed to the fatty acid profiles of TAG and PL in the serum. In particular, the decrease in proportion of 18:1n-7 was a common feature of TAG and PL in the serum of SHRSP. 18:1n-7 can be derived from the diet or biosynthetic pathway. In the liver, 18:1n-7 is synthesized from 16:0 via 16:1n-7; namely, 16:0 is desaturated by SCD1 to 16:1n-7, which is subsequently elongated by mainly Elovl5 to form 18:1n-7 48 . It was suggested from the present results that the decreases in content and proportion of 18:1n-7 in the liver of SHRSP are responsible for metabolic alterations brought about in the liver, the changes that are due to down-regulation of the activity of POCE and the expression of the Elovl5 gene in the liver of SHRSP, but not SHR, without alterations in the activity of SCD and the expression of the SCD1 gene. The present results showed that the contents of 16:1n-7 and 18:1n-9 in the liver of SHRSP were less than those of WKY and SHR, the extents that were not so marked as the case of 18:1n-7, despite the fact that there was no significant difference in SCD activity among the three groups of animals. Moreover, the current data revealed that hepatic content of 18:0 in SHRSP was significantly greater than those of controls, despite the facts that hepatic PCE activity in SHRSP was substantially the same as those in WKY and SHR. These discrepancies between fatty acid composition and activities of SCD and PCE can be elucidated by taking the differences in distribution of individual fatty acids among lipid classes into consideration. Namely, in the liver of WKY and SHR, 18:0 that was localized in TAG was less than 5 of total 18:0; on the other hand, 16:1n-7 and 18:1n-9, but not 18:1n-7, resided in TAG in higher proportion 42-58 than did 18:0. It is considered that fatty acids, which are released from TAG by the action of ATGL, subsequently by other lipase s , are prone to undergo mitochondrial β-oxidation 49 . Moreover, it has been demonstrated that 18:0 is poorly oxidized by mitochondrial β-oxidation when compared to monounsaturated fatty acids 50 52 . Therefore, it is likely that the content of 18:0 in hepatic lipid relatively increased and, conversely, those of 161:n-7 and 18:1n-9 relatively decreased in the liver of SHRSP compared to WKY and SHR, because the current data revealed up-regulation of ATGL and CPT1a in the liver of SHRSP. Recently, 16:1n-7 has been identified as an adipose tissue-derived lipid hormone capable of enhancing muscle insulin sensitivity in mice 24 . On the other hand, the physi- 12 . However, the authors did not show the proportion of 18:1n-7, which could be synthesized from 16:1n-7 by POCE, in organs and plasma. Therefore, it is still unclear whether the preventive effects that were observed with 16:1n-7 are due to 16:1n-7 or 18:1n-7. These findings may enable one to speculate that the reduced content and proportion of 18:1n-7 in the liver have pathophysiological importance in the pathogenesis of disorders of the metabolism of fatty acids and TAGs in SHRSP.
In conclusion, the present study clearly showed that profiles of lipid classes and fatty acids in the liver and serum of SHRSP were significantly different from those of SHR. The characteristic alterations brought about in the liver and serum of SHRSP are 1 decreased content of TAGs in the liver, 2 altered gene expression that leads to reduced TAGs and fatty acids in the liver, 3 decreased contents and proportions of monounsaturated fatty acids, in particular 18:1n-7, in the liver and serum, and 4 the down-regulation of POCE in the liver. From the above observations, we concluded that there are significant differences in the profiles of lipid classes and fatty acids between SHRSP and SHR, and that the alterations specific for SHRSP are likely responsible for increases in TAG hydrolysis and β-oxidation, and decreases in TAG synthesis and 18:1n-7 synthesis. Considering the recently reported feature of 18:1n-7 as a possible signaling molecule, the results obtained in the present study may provide basic information that is valuable for studies on the etiology of disorders in lipid metabolism in SHRSP.
